Capital International Investors

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1562230 Los Angeles, CA

Position in AGIO

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,644,679

-$17,514,526 QoQ

Shares Held

48,616

-93.1% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Capital International Investors holds $7,233,634,148 across 15 Biotechnology names. AGIO ranks #15 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,126,077	$2,288,998,423
2	RPRX	Royalty Pharma plc	35,005,736	$1,679,225,155
3	ONC	BeOne Medicines Ltd.	4,158,726	$1,235,016,860
4	INSM	INSMED Inc	5,595,194	$914,926,122
5	ASND	Ascendis Pharma A/S	1,958,843	$448,046,159
6	XENE	Xenon Pharmaceuticals Inc.	2,674,727	$155,535,375
7	RAPP	Rapport Therapeutics, Inc.	3,097,973	$96,935,575
8	CYTK	Cytokinetics Inc	1,338,803	$88,240,505

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,644,679	48,616	-93.1%	Shares	Defined	2026-05-13
2025-12-31	$19,159,205	703,865	+634.1%	Shares	Defined	2026-02-11
2021-06-30	$5,284,057	95,882	0.0%	Shares	Defined	2021-08-16
2021-03-31	$4,951,346	95,882	-56.0%	Shares	Defined	2021-05-14
2020-12-31	$9,448,106	218,050	-93.7%	Shares	Defined	2021-02-12
2020-09-30	$120,237,355	3,435,353	-10.9%	Shares	Defined	2020-11-13
2020-06-30	$206,156,415	3,854,832	-3.4%	Shares	Defined	2020-08-14
2020-03-31	$141,512,689	3,988,520	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.